SCHEMBL4850756

SCHEMBL4850756

C(=N/N(c1ccccc1)c1ccccc1)\c1cn(CC2CO2)c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
EIF4H Q15056 1/20 0.43
ALDH1A1 P00352 9/20 0.40
HSD17B10 Q99714 2/20 0.40
DHFR P00374 1/20 0.40
CYP2C19 P33261 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
GAA P10253 5/20 0.38
MAPK1 P28482 4/20 0.38
TSHR P16473 1/20 0.38
PTGS2 P35354 3/20 0.37
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 4/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4850760 1.00 POLB (0.43) POLBEIF4HALDH1A1HSD17B10DHFR
SCHEMBL4846031 0.77 DHFR (0.51) POLBALDH1A1DHFRL3MBTL1KMT2A
SCHEMBL4814026 0.74 DHFR (0.47) POLBALDH1A1HSD17B10DHFRCYP2C19
SCHEMBL4814020 0.74 DHFR (0.47) POLBALDH1A1HSD17B10DHFRCYP2C19
SCHEMBL14196855 0.72 USP2 (0.42) POLBEIF4HALDH1A1DHFRCYP2C19
SCHEMBL4823145 0.72 CYP1A2 (0.48) POLBALDH1A1HSD17B10DHFRCYP2C19
SCHEMBL4820619 0.72 CYP1A2 (0.48) POLBALDH1A1HSD17B10DHFRCYP2C19
SCHEMBL14352700 0.70 DHFR (0.53) DHFRL3MBTL1GAAMEN1KMT2A
SCHEMBL27691989 0.69 DHFR (0.51) DHFRL3MBTL1MEN1KMT2AMAPT
SCHEMBL14196857 0.68 POLB (0.40) POLBEIF4HALDH1A1HSD17B10DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7364825-B2 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-04-29 US disclosed
US-7364825-B2 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-04-29 US disclosed
US-7364825-B2 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-04-29 US disclosed
US-20060177750-A1 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group S-PRINTING SOLUTION CO., LTD. (KR) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060177750-A1 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group SLC1A2, SLC9B2, SLC6A19 POLB 3652/4885EIF4H 3382/4885ALDH1A1 1928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.